News and Press

October 14, 2013

BCSI Announces Efforts to Use pH Monitoring to Identify Compromised Platelet Products

DENVER, CO – October 14, 2013 – Blood Cell Storage, Inc. (BCSI), a leading medical device provider based in Seattle, WA announced today during the annual AABB meeting in Denver, Colorado, that they are exploring the viability of using the pH SAFE® products with regular pH readings to identify compromised platelet products.  Laboratory studies are underway whereby multiple daily pH measurements are being collected and where significant changes are being assessed in correlation with bacterial contamination. This research is important in the effort to help identify and remove bacterially contaminated platelet units from inventory. Older platelets can also be pH monitored to ensure their acceptable performance. “Since visual signs of contamination are difficult to detect,” said Russ Aldrich, CEO, BCSI. “We believe that using pH measurements to alert for possible bacterial contamination may be an additional way to identify compromised platelet products.” About BCSI Blood Cell Storage, Inc. (BCSI) www.bloodcellstorage.com... View Article

October 14, 2013

BCSI Announces Americas Launch of SAFE Sens IVM at ASRM; Novel New Approach to Monitor pH in Closed Incubator for In Vitro Fertilization (IVF)

BOSTON, MA – October 14, 2013 – Blood Cell Storage, Inc. (BCSI), a leading medical device provider based in Seattle, WA announced today during the American Society for Reproductive Medicine (ASRM) annual event in Boston, that their newest product, SAFE Sens IVM (in vessel monitoring), has begun shipping to customers and is generally available. SAFE Sens IVM, is a pH monitoring system used by embryologists and clinical staff, that reports, trends and archives pH measurements without disturbing culture conditions within a closed incubator. About SAFE SensTM The SAFE Sens (Sterile, Automated Fluoroscopic Evaluation) is an optical fluorescent measurement device. It is used in combination with a disposable sensor, to accurately and reliably measure the pH of small volumes of fluids such as the media used in IVF. The sensor contains a proprietary fluorescent dye that is pH sensitive. Each lot of sterile sensors last six (6) days and have a... View Article

October 2, 2013

BCSI is attending ASRM 2013

Come visit us at ASRM in Booth #548 from 13-16 October 2013 in Boston, MA.  Contact us if you plan on being there, too.

July 8, 2013

BCSI and Planer Announce Partnership to Address Shortcomings of Current pH Monitoring Processes in Medical Clinics and Labs

LONDON, UK – July 08, 2013 – BCSI, a leading medical device provider and Planer PLC, specialists in controlled temperature environments for medical labs and clinics, announced a partnership today during the annual meeting of European Society of Human Reproduction and Embryology (ESHRE). The two companies will collaborate on bringing new technologies to market to address current issues in pH monitoring for Invitro Fertilizaton (IVF) and other uses.“We are transferring our years of experience in blood storage to other areas where our technology can have a big impact,” said Russ Aldrich, CEO, BCSI. “Because of that experience we are seeing early positive results with this technology in areas such as assisted reproduction.”“We are excited and proud about the use of our bench-top incubators for assisted reproductive procedures such as IVF,” said Geoffrey Planer, CEO, Planer. “Partnering with BCSI ensures that together we will continue to advance the overall effort for better outcomes for... View Article

July 8, 2013

BCSI and tech²ART Announce Partnership to Address Shortcomings of Current pH Monitoring Processes in Medical Clinics and Labs

LONDON, UK – July 08, 2013 – BCSI, a leading medical device provider and tech²ART, specialists in Assisted Reproduction Technology (ART), announced a partnership today during the annual meeting of European Society of Human Reproduction and Embryology(ESHRE). The two companies will collaborate on bringing new technologies to market to address current issues in pH monitoring for Invitro Fertilizaton (IVF) and other uses.“Bringing together global experts in ART is an important part of the effort to improve outcomes for clinics and families,” said Russ Aldrich, CEO, BCSI. “The tech²ART team is energetic and focused and we look forward to a successful partnership.”“BCSI and the SAFE Sens technology they’ve created have an opportunity to make a real impact,” said Michael Similie, General Manager, tech²ART. “Our companies respective strengths are very synergistic and should bring better outcomes faster as we work together to get the technology into clinics.”About tech²ARTtech²ART Inc. www.tech2art.com is a privately held company that... View Article

July 8, 2013

BCSI and Origio Announce Partnership to Advance Closed Incubator pH Monitoring Processes Used for In Vitro Fertilization (IVF)

LONDON, UK – July 08, 2013 – Blood Cell Storage, Inc. (BCSI), a leading medical device provider based in Seattle, WA and Origio A/S, a leader in delivering innovative Assisted Reproductive Technology solutions headquartered in Måløv Denmark, announced a partnership today during the annual meeting of the European Society of Human Reproduction and Embryology (ESHRE). The two companies will collaborate on bringing new solutions for pH measurement to market to address current issues in monitoring for In Vitro Fertilization (IVF). The first product they will focus on is SAFE Sens IVM, a pH monitoring system used by clinical and research staff, that reports, trends and archives pH measurements without disturbing culture conditions within a closed incubator.“Embryologists want to monitor pH within media to minimize pH drift and improve their success rates,” said Jesper Funding Andersen, CEO, Origio. “SAFE Sens is easy-to-use, lasts the entire cycle and provides validation to ensure that the system... View Article

June 24, 2013

BCSI at ESHRE

BCSI will be attending the ESHRE event in London, England from July 8- July 11, 2013. Contact us if you plan on being there, too.

August 16, 2012

New Monitoring Device to Increase the Safety of Blood Transfusions

The US Army Medical Research and Material Command, Telemedicine & Advance Technology Research Center Highlights their involvement with the pH SAFE technology as a way to increase the safety of blood transfusions. Read the full article here (pdf).

May 24, 2011

Sanquin announces completion of 15,000 platelet bag evaluation

Sanquin, the blood supply repository and authority for the Netherlands, announced completion of a 15,000 platelet bag evaluation on March 28, 2011 with the data analysis of the Blood Cell Storage, Inc. (BCSI) pH1000 system; a non-invasive pH level detection system using a fluorescent sensor and automated reader. As a result of this study they have now released a request for bids on new platelet collection sets. As an option on those sets they desire the inclusion of the BCSI pH system. BCSI is pleased to be currently working with platelet bag suppliers to integrate our non-invasive pH sensors into their offerings for Sanquin’s platelet collection sets.

January 1, 2010

BCSI Wins Fiscal Year 2010 Department of Defense Appropriation

BCSI has been approved to receive a $1.6M U.S. Fiscal Year 2010 Defense Appropriation as included in the Department of Defense appropriations bill submitted by U.S. Senator Patty Murray, approved by both houses and signed by the President. Senator Murray indicated that, “This funding would help the Army develop a capability to ensure the efficacy of platelets in large samples. Platelets are necessary to stop blood loss from severe injuries. This project would help reduce battlefield deaths caused by transfusions of ineffective platelets.”The DOD appropriation recognizes the importance of rapid, user friendly measurement of pH to assure the quality of platelets for transfusions utilizing BCSI proprietary technology.